[1] OVERHOLTZER M, ZHANG J, SMOLEN G A, MUIR B, LI W, SGROI D C, DENG C X, BRUGGE J S, HABER D A. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(33):12405-12410.
[2] 史梦婕, 邵松军, 李洁媚, 周艳芳, 黄培春. Hippo通路与肿瘤相关性研究进展. 中国细胞生物学学报, 2014, 36(3):361-365.
SHI M J, SHAO S J, LI J M, ZHOU Y F, HUANG P C. The advances in Hippo pathway association with cancer. Chinese Journal of Cell Biology, 2014, 36(3):361-365.(in Chinese)
[3] 张靖, 朱金水. Hippo-YAP信号通路与胃癌相关性研究. 国际消化病杂志, 2011, 31(4):207-215.
ZHANG J, ZHU J S. The advances in Hippo signaling pathway association with gastric cancer. International Journal of Digestive Disease, 2011, 31(4):207-215.(in Chinese)
[4] NGUYEN L T, TRETIAKOVA M S, SILVIS M R, LUCAS J, KLEZOVITCH O, COLEMAN I, BOLOURI H, KUTYAVIN V I, MORRISSEY C, TRUE L D, NELSON P S, VASIOUKHIN V. ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors. Cancer Cell, 2015, 27(6):797-808.
[5] MELFI S, COLCIAGO A, GIANNOTTI G, BONALUME V, CAFFINO L, FUMAGALLI F, MAGNAGHI V. Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells. Cell Death and Disease, 2015, 6:e1915. doi: 10.1038/cddis.2015.291.
[6] CAO X, PFAFF S L, GAGE F H. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes and Development, 2008, 22(23):3320-3334.
[7] PLOUFFE S W, HONG A W, GUAN K L. Disease implications of the Hippo/YAP pathway. Trends in Molecular Medicine, 2015, 21(4): 212-222.
[8] MOUSTAKAS A, SOUCHELNYTSKYI S, HELDIN C H. Smad regulation in TGF-beta signal transduction. Journal of Cell Science, 2001, 114(Pt 24):4359-4369.
[9] XU P, LIU J, DERYNCK R. Post-translational regulation of TGF-β receptor and Smad signaling. Febs Letters, 2012, 586(14):1871-1884.
[10] MOUSTAKAS A, HELDIN C H. The regulation of TGFbeta signal transduction. Development, 2009, 136(22):3699-3714.
[11] WAKEFIELD L M, HILL C S. Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nature Reviews Cancer, 2013, 13(5): 328-341.
[12] IKUSHIMA H, MIYAZONO K. TGFbeta signalling: a complex web in cancer progression. Nature Reviews Cancer, 2010, 10(6):415-424.
[13] YAN X, LIAO H, CHENG M, SHI X, LIN X, FENG X H, CHEN Y G. Smad7 protein interacts with Receptor regulated Smads (R-Smads)- Smads to inhibit transforming growth factor-β(TGF-β)/Smad signaling. Journal of Biological Chemistry, 2016, 291: 382-392.
[14] LÖNN P, MORÉN A, RAJA E, DAHL M, MOUSTAKAS A. Regulating the stability of TGFbeta receptors and Smads. Cell Research, 2009, 19(1):21-35.
[15] FERRIGNO O, LALLEMAND F, VERRECCHIA F, L'HOSTE S, CAMONIS J, ATFI A, MAUVIEL A. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene, 2002, 21(32):4879-4884.
[16] SCHILD L, LU Y, GAUTSCHI I, SCHNEEBERGER E, LIFTON R P, ROSSIER B C. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO Journal, 1996, 15(10): 2381-2387.
[17] 孙伟, 李达, 苏锐, 马月辉, 关伟军, 张有法, 陈玲, 吴文忠, 周洪. 绵羊YAP1 基因全长cDNA 克隆及生物信息学分析. 中国农业科学, 2013, 46(8):1725-1735.
SUN W, LI D, SU R, MA Y H, GUAN W J, ZHANG Y F, CHEN L, WU W Z, ZHOU H. Cloning and bioinformatics analysis of full- length cDNA sequence of YAP1 gene in sheep. Scientia Agricultura Sinica, 2013, 46(8):1725-1735.(in Chinese)
[18] KOLLIAS H D, MCDERMOTT J C. Transforming growth factor-beta and myostatin signaling in skeletal muscle. Journal of Applied Physiology, 2008, 104(3):579-587.
[19] NAKAMURA R, KAYAMORI K, OUE E, SAKAMOTO K, HARADA K, YAMAGUCHI A. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma. Biochemical and Biophysical Research Communications, 2015, 458(4):777-782.
[20] FUJII M, TOYODA T, NAKANISHI H, YATABE Y, SATO A, MATSUDAIRA Y, ITO H, MURAKAMI H, KONDO Y, KONDO E, HIDA T, TSUJIMURA T, OSADA H, SEKIDO Y. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. Journal of Experimental Medicine, 2012, 209(3): 479-494.
[21] NAKAO A, AFRAKHTE M, MORÉN A, NAKAYAMA T, CHRISTIAN J L, HEUCHEL R, ITOH S, KAWABATA M, HELDIN N E, HELDIN C H, TEN DIJKE P. Identification of Smad7, a TGF beta-inducible antagonist of TGF-beta signaLling. Nature, 1997, 389(6651):631-635.
[22] BEPPU H. Smad7-modified alleles by various gene-targeting strategies. Journal of Biochemistry, 2013, 153(5):399-401.
[23] DROGUETT R, CABELLO-VERRUGIO C, SANTANDER C, BRANDAN E. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Experimental Cell Research, 2010, 316(15):2487-2503.
[24] FOURNIER P G, JUÁREZ P, JIANG G, CLINES G A, NIEWOLNA M, KIM H S, WALTON H W, PENG X H, LIU Y, MOHAMMAD K S, WELLS C D, CHIRGWIN J M, GUISE T A. The TGF-β signaling regulator PMEPA1 suppresses prostate cancer metastases to bone. Cancer Cell, 2015, 27(6):809-821.
[25] NAKAO A, IMAMURA T, SOUCHELNYTSKYI S, KAWABATA M, ISHISAKI A, OEDA E, TAMAKI K, HANAI J, HELDIN CH, MIYAZONO K, TEN DIJKE P. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO Journal, 1997, 16(17): 5353-5362.
[26] 徐业芬. Smad信号转导通路相关基因表达与湖羊高繁殖力关系的研究[D]. 南京: 南京农业大学, 2010.
XU Y F. Gene expressions related to smad sigenaling molecule and its relationship with fecundity in Hu sheep[D]. Nanjing: Nanjing Agricultural University, 2010.(in Chinese)
[27] GOLDSTEIN J A, BOGDANOVICH S, BEIRIGER A, WREN L M, ROSSI A E, GAO Q Q, GARDNER B B, EARLEY J U, MOLKENTIN J D, MCNALLY E M. Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy. Human Molecular Genetics, 2014, 23(25):6722-6731.
[28] COHEN T V, KOLLIAS H D, LIU N, WARD C W, WAGNER K R. Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration. Journal of Physiology, 2015, 593(11):2479-2497.
[29] GUO J, KLEEFF J, ZHAO Y, LI J, GIESE T, ESPOSITO I, BÜCHLER M W, KORC M, FRIESS H. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. International Journal of Molecular Medicine, 2006, 17(5):761-767.
[30] SUN J G, CHEN X W, ZHANG L P, WANG J, DIEHN M. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling. Oncotarget, 2015, doi: 10.18632/ oncotarget.6655. |